مؤتمر
PO004LBA/#1515 Efficacy and safety of avutometinib + defactinib in recurrent low-grade serous ovarian cancer following prior systemic therapy
العنوان: | PO004LBA/#1515 Efficacy and safety of avutometinib + defactinib in recurrent low-grade serous ovarian cancer following prior systemic therapy |
---|---|
المؤلفون: | Grisham, Rachel, Aghajanian, Carol, Nieuwenhuysen, Els Van, Rodrigues, Manuel, Ring, Kari, Santin, Alessandro, Colombo, Nicoletta, Prendergast, Emily, Thaker, Premal, Moore, Kathleen, Salinas, Erin, Ray-Coquard, Isabelle, Chon, Hye Sook, Rose, Peter, Oaknin, Ana, Clamp, Andrew, Gandhi, Mitul, Monk, Bradley, Holloway, Robert, Gorp, Toon Van, Fabbro, Michel, Gennigens, Christine, Wojtynek, Nicholas, Lustgarten, Stephanie, Banerjee, Susana |
المصدر: | International Journal of Gynecological Cancer (2023-11); IGCS 2023, Seoul, South Korea [KR], 5-7 November 2023 |
بيانات النشر: | BMJ Publishing Group Ltd, 2023. |
سنة النشر: | 2023 |
مصطلحات موضوعية: | Human health sciences, Oncology, Sciences de la santé humaine, Oncologie |
نوع الوثيقة: | conference paper http://purl.org/coar/resource_type/c_5794 conferenceObject peer reviewed |
اللغة: | English |
Relation: | https://syndication.highwire.org/content/doi/10.1136/ijgc-2023-IGCS.4; urn:issn:1048-891X; urn:issn:1525-1438 |
DOI: | 10.1136/ijgc-2023-igcs.4 |
URL الوصول: | https://orbi.uliege.be/handle/2268/311324 |
حقوق: | restricted access http://purl.org/coar/access_right/c_16ec info:eu-repo/semantics/restrictedAccess |
رقم الأكسشن: | edsorb.311324 |
قاعدة البيانات: | ORBi |
DOI: | 10.1136/ijgc-2023-igcs.4 |
---|